Small increased risk of acute coronary events with dabigatran Clinical study 12 January 2013 Pages: 2 - 2
The public is informed by the US FDA that an additional concentration of infants’ liquid paracetamol News item 12 January 2013 Pages: 5 - 5
The EMA’s Pharmacovigilance Working Party (PhVWP) is recommending an update to the product labelling for rosuvastatin, News item 12 January 2013 Pages: 5 - 5
Bedford Laboratories has issued guidance on the voluntary recall of Polymyxin B for injection USP Media release 12 January 2013 Pages: 5 - 5
The US FDA is informing of two additional cases of progressive multifocal leukoencephalopathy (PML) associated with brentuximab vedotin [Adcetris].* News item 12 January 2013 Pages: 5 - 5